Literature DB >> 30149734

European Pharma Oligonucleotide Consortium: A Move to Consolidate Oligonucleotide Knowledge and Share Experience Within the Community.

Anna Tivesten1, Nadim Akhtar2, Jessica Stolee3, Yannick Fillon3, Rachel Orr4, Malcolm L Hill4, Leo Van den Bergh5, Tom Huybrechts5, Jale Muslehiddinoglu5, Paul McCormac6, John Amery7, Andrea Brecht8, Achim Geiser8, Tobias Metzenthin9, Thomas Eichinger9.   

Abstract

A consortium of seven pharma companies has been formed with the aim of sharing knowledge on and harmonizing approaches to oligonucleotide development. This letter aims to raise awareness of this new group and to set expectations for future publications.

Entities:  

Keywords:  collaboration; consortium; harmonization; oligonucleotide; pre-competitive; prior knowledge

Mesh:

Substances:

Year:  2018        PMID: 30149734     DOI: 10.1177/2168479018793626

Source DB:  PubMed          Journal:  Ther Innov Regul Sci        ISSN: 2168-4790            Impact factor:   1.778


  1 in total

Review 1.  Solution Oligonucleotide APIs: Regulatory Considerations.

Authors:  Christian Wetter; Chris Chorley; Corrine Curtis; Nicole Del Canto; J Gair Ford; Jennifer Franklin; Cinzia Gazziola; Michael T Jones; Judy Lee; Arnold McAuley; Florence C E Saraber; Audrey Scott; Janine Tom
Journal:  Ther Innov Regul Sci       Date:  2022-02-08       Impact factor: 1.778

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.